Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor

Breast Care - Switzerland
doi 10.1159/000321426
Full Text
Abstract

Available in full text

Categories
SurgeryOncology
Date
Authors
Publisher

S. Karger AG

Related search

Autoimmune Hepatitis Deteriorated by Anastrozole, an Aromatase Inhibitor, for Breast Cancer Adjuvant Chemotherapy

Acta Hepatologica Japonica
Hepatology
2014English

Efficacy of Management Strategies for Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Patients: A Systematic Review

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2018English

Kinetics, Prognostic and Predictive Values of ESR1 Circulating Mutations in Metastatic Breast Cancer Patients Progressing on Aromatase Inhibitor

Oncotarget
Oncology
2016English

Letrozole (CGS 20267), a New Oral Aromatase Inhibitor for the Treatment of Advanced Breast Cancer in Postmenopausal Patients

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1996English

Forskolin Increases the Effect of Everolimus on Aromatase Inhibitor-Resistant Breast Cancer Cells

Oncotarget
Oncology
2018English

Accumulation of P53 Is Prognostic for Aromatase Inhibitor Resistance in Early-Stage Postmenopausal Patients With ER-positive Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2015English

Profiles of miRNAs Matched to Biology in Aromatase Inhibitor Resistant Breast Cancer

Oncotarget
Oncology
2016English

Periodontal Health in Breast Cancer Patients on Aromatase Inhibitorsversuspostmenopausal Controls: A Longitudinal Analysis

Journal of Clinical Periodontology
Periodontics
2016English

Managing Arthralgia in a Postmenopausal Woman Taking an Aromatase Inhibitor for Hormone-Sensitive Early Breast Cancer: A Case Study

Cancer Management and Research
Oncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy